Body Weight-Based Protocols During Whole Body FDG PET/CT Significantly Reduces Radiation Dose without Compromising Image Quality:Findings in a Large Cohort Study

Acad Radiol. 2019 May;26(5):658-663. doi: 10.1016/j.acra.2018.07.014. Epub 2018 Aug 23.

Abstract

Rationale and objectives: To investigate radiation dose reduction during whole body fluorodeoxyglucose (18F-FDG) positron emission tomographic (PET)/computed tomography (CT) by employing weight-based protocols.

Materials and methods: One thousand and twenty-eight patients were referred for 18F-FDG PET/CT study with one of two protocols: conventional protocol I; 120 kVp, 120 mAs, 0.5 second rotation time, pitch 0.8 mm/rot across all body weights; four-tier body weight protocol II all used 140 kVp, 0.75 seconds rotation time and pitch 0.8 mm/rot: Protocol A (≤60 kg): 35 mAs, Protocol B (61-80 kg): 50 mAs, Protocol C (81-100 kg): 65 mAs, and Protocol D: (>101 kg): 100 mAs. All protocols employed tube current modulation. Quantitative and qualitative image visual grading characteristics assessed image quality.

Results: Patient demographics demonstrated no significant difference between each protocol except for patient weight in weight protocol IIB (p < 0.009). Mean effective dose in all protocols were significantly lower in Protocol B compared to A (p < 0.009). Contrast-to-noise ratio demonstrated no differences between each protocol (p < 0.21) except for weight protocol in protocol IIA (<60 kg, p = 0.035) with the visual grading characteristics demonstrating preference over protocol II compared to I.

Conclusion: Significant reduction in radiation dose can be achieved using patient-specific body weight-based protocols during whole-body 18F-FDG PET/CT without compromising image quality when employing weight-based protocols.

MeSH terms

  • Body Weight*
  • Clinical Protocols
  • Cohort Studies
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography / methods*
  • Radiation Dosage
  • Radiation Exposure / prevention & control*
  • Radiopharmaceuticals
  • Retrospective Studies
  • Signal-To-Noise Ratio

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18